Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program
Open Access
- 1 October 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 3 (4) , ofw193
Abstract
Background. Outpatient parenteral antibiotic therapy (OPAT) is a safe and effective modality for treating serious infections. This study was undertaken to define the value of OPAT in a multicentered infectious disease (ID) private practice setting. Methods. Over a period of 32 months, 6120 patients were treated using 19 outpatient ID offices in 6 states. Analysis included patient demographics, indications of OPAT, diagnoses, therapeutic agent, duration of therapy, and site of therapy initiation. Outcomes were stratified by therapeutic success, clinical relapse, therapeutic complications, and hospitalizations after initiating therapy. Statistical analysis included an ordinal logistic regression analysis. Results. Forty-three percent of patients initiated therapy in an outpatient office, and 57% began therapy in a hospital. Most common diagnoses treated were bone and joint (32.2%), abscesses (18.8%), cellulitis (18.5%), and urinary tract infection (10.8%). Ninety-four percent of patients were successfully treated, and only 3% were hospitalized after beginning therapy. Most common cause of treatment failure was a relapse of primary infection (60%), progression of primary infection (21%), and therapeutic complication (19%). Conclusions. An ID-supervised OPAT program is safe, efficient, and clinically effective. By maximizing the delivery of outpatient care, OPAT provides a tangible value to hospitals, payers, and patients. This program is a distinctive competency available to ID physicians who offer this service to patients.Keywords
This publication has 18 references indexed in Scilit:
- Prediction Model for 30-Day Hospital Readmissions Among Patients Discharged Receiving Outpatient Parenteral Antibiotic TherapyClinical Infectious Diseases, 2013
- Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare CostsClinical Infectious Diseases, 2013
- Hospitalist to Home: Outpatient Parenteral Antimicrobial Therapy at an Academic CenterClinical Infectious Diseases, 2010
- Outpatient Parenteral Antimicrobial Therapy TodayClinical Infectious Diseases, 2010
- Home Intravenous Antimicrobial Infusion Therapy: A Viable Option in Older AdultsJournal of the American Geriatrics Society, 2007
- Practice Guidelines for Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2004
- EVOLUTION OF OUTPATIENT PARENTERAL ANTIBIOTIC THERAPYInfectious Disease Clinics of North America, 1998
- OUTPATIENT ANTIBIOTIC THERAPY IN LONG-TERM CARE FACILITIESInfectious Disease Clinics of North America, 1998
- Cost-effectiveness of outpatient parenteral antibiotics: A review of the literatureThe American Journal of Medicine, 1989
- Feasibility of outpatient self-administration of parenteral antibiotics.1978